U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 41 - 41 of 41 results

HYPERICUM PERFORATUM WHOLE

MORE DETAILS

XK4IUX8MNB

structurally diverse
Status:
Possibly Marketed Outside US
Source:
NCT02862236: Phase 4 Interventional Completed Subclinical Anxious Adults
(2017)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT02862236
First approved in 2009
Source:
21 CFR 352
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=97a31203-7bbd-4b67-a860-0d30de428bdf
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966